Home | A panel of markers for the prediction of epilepsy relapse in patients with tuberous sclerosis, an in vitro method for predicting the occurrence of epileptic relapse in patients with tuberous sclerosis, and the use of a panel of markers in this method
Diagnostics
A panel of markers for the prediction of epilepsy relapse in patients with tuberous sclerosis, an in vitro method for predicting the occurrence of epileptic relapse in patients with tuberous sclerosis, and the use of a panel of markers in this method
Patent inventors: Adria-Jaume Roura Canalda, Bartłomiej Gielniewski, Jacek Jaworski, Sergiusz Jóźwiak, Bożena Kamińska-Kaczmarek, Katarzyna Kotulska-Jóźwiak, Ewa Liszewska, Bartosz Wojtas
A panel of blood RNA markers for the prediction of the occurrence of epilepsy recurrence following drug withdrawal in male patients with tuberous sclerosis, characterised in that it comprises following markers P2RY13, IL13RA1, PDE4B (and at least one chosen from PTGS2, RGCC, PPP1R3F, TLE2, LZTS3, SERINC3, TMEM238).
Nencki Institute is the co-applicant with Medical University of Warsaw, International Institute of Molecular and Cell Biology in Warsaw, and Children's Memorial Health Institute in Warsaw. Medical University of Warsaw is the leader in patent protection and commercialization-related activities.
For more information contact Technology Transfer Office.
Application number:
P.440701 and EP22163365.4 (21.03.2022)
Patent status:
pending